Wolfgang Miesbach։ Thrombosis After Haemophilia B Gene Therapy
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared post on LinkedIn:
”Newly reported at ISTH2026: bilateral pulmonary emboli after gene therapy for haemophilia B.
A 52-year-old man with moderately severe haemophilia B (FIX less than 2 percent), physically active, with no thrombotic risk factors, received 1 times 10 to the 12th vg per kg fidanacogene elaparvovec in a Pfizer-sponsored trial in May 2023 — twice the licensed dose of 5 times 10 to the 11th vg per kg.
For two years, his FIX activity fluctuated but was repeatedly supranormal. Then, at week 108: DVT and bilateral pulmonary emboli on CTPA, now requiring long-term anticoagulation.
Not the first thrombotic event reported after haemophilia B gene therapy: B-AMAZE (FLT180a) reported an AV fistula thrombosis at 1.28 times 10 to the 12th vg per kg, with FIX levels reaching approximately 310 percent.
Assay discrepancy, followed through week 120:
- One-stage SynthASil, local: plateau 120 to 160 percent, peaks approximately 180 percent.
- One-stage SynthASil, central: approximately 220 percent early and again near week 104, approximately 185 percent at the time of the event.
- One-stage Actin-FSL: mostly 80 to 110 percent, but three discordant spikes of 310 percent or higher, and only approximately 130 percent on the day of thrombosis.
- Chromogenic: 0.6 to 1.0 IU per mL throughout, never above the upper limit.

Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience
-
Nov 12, 2026, 22:46Ashish Sharma: In-Hospital Mortality and Bleeding Complications in APL